TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

NCT00442832 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Skin Infection

Interventions

DRUG: TD-1792
DRUG: Vancomycin

Sponsor

Theravance Biopharma